Sequana Medical NV's book value per share for the quarter that ended in Jun. 2023 was €-0.13.
During the past 12 months, Sequana Medical NV's average Book Value Per Share Growth Rate was -118.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Sequana Medical NV was 68.70% per year. The lowest was -303.00% per year. And the median was -117.15% per year.
During the past 9 years, the highest P/B Ratio of Sequana Medical NV was 1685.71. The lowest was 69.04. And the median was 511.81.
Sequana Medical NV Book Value per Share Historical Data
The historical data trend for Sequana Medical NV's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sequana Medical NV's Book Value per Share
For the Medical Devices subindustry, Sequana Medical NV's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sequana Medical NV's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sequana Medical NV's PB Ratio falls into.
Sequana Medical NV Book Value per Share Calculation
Sequana Medical NV's Book Value Per Share for the fiscal year that ended in Dec. 2022 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Sequana Medical NV (XBRU:SEQUA) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Sequana Medical NV Book Value per Share Related Terms
Thank you for viewing the detailed overview of Sequana Medical NV's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Sequana Medical NV (XBRU:SEQUA) Business Description
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBRU:SEQUA has been successfully added to your 